Compounds > valine

valine and Invasiveness, Neoplasm

valine has been researched along with Invasiveness, Neoplasm in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (14.29)18.2507
2000's3 (21.43)29.6817
2010's9 (64.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ding, X; Dong, Y; Gu, W; Song, X; Wang, Z; Wu, Y; Zhang, W; Zheng, Y; Zhong, Y1
Guan, H; Liu, R; Liu, X; Murugan, AK; Qu, S; Shan, Z; Sheng, C; Shi, X; Sun, H; Teng, W; Wang, Y; Xing, M; Yu, H; Zhu, G1
Aymerich, M; Campo, E; Colomer, D; López-Guerra, M; López-Otín, C; Matas-Céspedes, A; Montraveta, A; Pérez-Galán, P; Roldán, J; Rosich, L; Roué, G; Villamor, N; Xargay-Torrent, S1
Coombes, RC; Faronato, M; Filipovic, A; Lombardo, Y; Magnani, L; Vircillo, V1
Al Sannaa, GA; Bolshakov, S; Braggio, D; Creighton, CJ; Lazar, AJ; Lee, YJ; Lev, D; Pollock, RE; Shang, H1
Byun, HJ; Kang, GJ; Kim, EJ; Kim, HJ; Lee, CH; Lee, H; Nam, S; Park, MK1
Wang, Q; Wu, G; Zhao, W1
Baggiani, A; Basolo, F; Berti, P; Elisei, R; Giannini, R; Lupi, C; Miccoli, M; Miccoli, P; Sensi, E; Torregrossa, L; Vitti, P1
Amato, MC; Bommarito, A; Carina, V; Carissimi, E; Criscimanna, A; Di Blasi, F; Galluzzo, A; Giordano, C; Latteri, MA; Modica, G; Pitrone, M; Pizzolanti, G; Richiusa, P; Rodolico, V; Spinelli, G; Zerilli, M; Zito, G1
Jedinak, A; Jiang, J; Krchňák, V; Sandusky, GE; Sliva, D; Thyagarajan-Sahu, A1
Abbe, P; Bahadoran, P; Bailet, O; Ballotti, R; Baron, V; Bertolotto, C; Gaggioli, C; Ortonne, JP; Robert, G; Spadafora, A; Tartare-Deckert, S1
Bakker, A; Finkelstein, SD; Sayegh, R; Swalsky, P1
Al-Mulla, F; Birnie, GD; Going, JJ; Milner-White, EJ1
Al-Mulla, F; MacKenzie, EM1

Other Studies

14 other study(ies) available for valine and Invasiveness, Neoplasm

ArticleYear
Combined Erlotinib and PF-03084014 treatment contributes to synthetic lethality in head and neck squamous cell carcinoma.
    Cell proliferation, 2018, Volume: 51, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Erlotinib Hydrochloride; Head and Neck Neoplasms; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Neoplasm Invasiveness; Signal Transduction; Tetrahydronaphthalenes; Tumor Burden; Valine; Xenograft Model Antitumor Assays

2018
TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.
    The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:6

    Topics: Adenocarcinoma, Follicular; Adult; Aged; Amino Acid Substitution; Base Sequence; Carcinoma; Carcinoma, Papillary; Cohort Studies; Female; Gene Frequency; Genetic Association Studies; Glutamic Acid; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation; Neoplasm Invasiveness; Promoter Regions, Genetic; Proto-Oncogene Proteins B-raf; Telomerase; Thyroid Cancer, Papillary; Thyroid Neoplasms; Valine

2014
The γ-secretase inhibitor PF-03084014 combined with fludarabine antagonizes migration, invasion and angiogenesis in NOTCH1-mutated CLL cells.
    Leukemia, 2015, Volume: 29, Issue:1

    Topics: Aged; Amyloid Precursor Protein Secretases; Enzyme Inhibitors; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Mutation; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Receptor, Notch1; Tetrahydronaphthalenes; Tumor Cells, Cultured; Valine; Vidarabine

2015
Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.
    Breast cancer research : BCR, 2014, Jun-11, Volume: 16, Issue:3

    Topics: Amyloid Precursor Protein Secretases; Antibodies, Monoclonal; Antineoplastic Agents, Hormonal; Breast Neoplasms; CD24 Antigen; Cell Movement; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; MCF-7 Cells; Membrane Glycoproteins; Neoplasm Invasiveness; Proto-Oncogene Proteins; Receptor, Notch1; Receptor, Notch2; Receptor, Notch4; Receptors, Notch; RNA Interference; RNA, Small Interfering; Selective Estrogen Receptor Modulators; Spheroids, Cellular; Tamoxifen; Tetrahydronaphthalenes; Tumor Cells, Cultured; Valine

2014
Targeting the Notch pathway: A potential therapeutic approach for desmoid tumors.
    Cancer, 2015, Nov-15, Volume: 121, Issue:22

    Topics: CCN Intercellular Signaling Proteins; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Fibromatosis, Aggressive; Humans; Neoplasm Invasiveness; Receptors, Notch; Repressor Proteins; Signal Transduction; Tetrahydronaphthalenes; Valine

2015
Novel effects of sphingosylphosphorylcholine on invasion of breast cancer: Involvement of matrix metalloproteinase-3 secretion leading to WNT activation.
    Biochimica et biophysica acta, 2016, Volume: 1862, Issue:9

    Topics: Breast Neoplasms; Caproates; Cell Line, Tumor; Female; Flavonoids; Gene Silencing; Humans; Matrix Metalloproteinase 3; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Phosphorylcholine; Polycyclic Compounds; Sphingosine; Valine; Wnt Signaling Pathway

2016
Valsartan inhibits NPC cell line CNE-2 proliferation and invasion and promotes its sensitivity to radiation.
    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2009, Volume: 18, Issue:6

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Apoptosis; Blotting, Western; Cell Adhesion; Cell Movement; Cell Proliferation; Cobalt Radioisotopes; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gamma Rays; Humans; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Radiation Tolerance; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Tumor Cells, Cultured; Valine; Valsartan; Vascular Endothelial Growth Factor A

2009
Correlation between the BRAF V600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1060 cases.
    The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:9

    Topics: Adult; Amino Acid Substitution; Carcinoma, Papillary; Cohort Studies; Female; Genetic Predisposition to Disease; Glutamic Acid; Humans; Male; Middle Aged; Neoplasm Invasiveness; Point Mutation; Proto-Oncogene Proteins B-raf; Retrospective Studies; Thyroid Neoplasms; Tumor Burden; Valine

2010
BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy.
    Endocrine-related cancer, 2011, Volume: 18, Issue:6

    Topics: Adult; Amino Acid Substitution; Carcinoma; Carcinoma, Papillary; Cell Transformation, Neoplastic; Disease Progression; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Glutamic Acid; Humans; Male; Middle Aged; Mutation, Missense; Neoplasm Invasiveness; NF-kappa B; Proto-Oncogene Proteins B-raf; Signal Transduction; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tissue Inhibitor of Metalloproteinase-1; Tumor Cells, Cultured; Up-Regulation; Valine

2011
NAHA, a novel hydroxamic acid-derivative, inhibits growth and angiogenesis of breast cancer in vitro and in vivo.
    PloS one, 2012, Volume: 7, Issue:3

    Topics: Amides; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Hydroxamic Acids; In Vitro Techniques; Mice; Mice, Nude; Models, Chemical; Neoplasm Invasiveness; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Valine; Vascular Endothelial Growth Factor A

2012
Tumor-derived fibronectin is involved in melanoma cell invasion and regulated by V600E B-Raf signaling pathway.
    The Journal of investigative dermatology, 2007, Volume: 127, Issue:2

    Topics: Cells, Cultured; Disease Progression; Early Growth Response Protein 1; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Fibronectins; Glutamic Acid; Humans; Melanocytes; Melanoma; Mutation; Neoplasm Invasiveness; Proto-Oncogene Proteins B-raf; Signal Transduction; Valine

2007
Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis.
    Archives of surgery (Chicago, Ill. : 1960), 1993, Volume: 128, Issue:5

    Topics: Adenocarcinoma; Aspartic Acid; Biomarkers, Tumor; Codon; Colonic Neoplasms; DNA, Neoplasm; Exons; Follow-Up Studies; Genes, ras; Glutamine; Histidine; Humans; Mutation; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Rectal Neoplasms; Retrospective Studies; Survival Rate; Valine

1993
Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression.
    The Journal of pathology, 1999, Volume: 187, Issue:4

    Topics: Aspartic Acid; Crystallography; Humans; Mutation; Neoplasm Invasiveness; Phosphates; Proto-Oncogene Proteins p21(ras); Signal Transduction; Structure-Activity Relationship; Valine

1999
Differences in in vitro invasive capacity induced by differences in Ki-Ras protein mutations.
    The Journal of pathology, 2001, Volume: 195, Issue:5

    Topics: Aspartic Acid; Blotting, Western; Cell Transformation, Neoplastic; Endothelial Growth Factors; Fibroblasts; Humans; Lymphokines; Mutation; Neoplasm Invasiveness; Proto-Oncogene Proteins p21(ras); Transfection; Tumor Cells, Cultured; Valine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2001